Skip to main content

Clinical trial J2J-MC-JZLA - EMBER

A Phase 1a/1b Study of LY3484356 Administered as Monotherapy and in Combination with Therapies for Patients with ER+, HER2-Locally Advanced or Metastatic Breast Cancer and Other Select Non-Breast Cancers

Organ Multiples
Trial status Trial open for recruitment
Trial type
Interventional with experimental drug
Phase Trial phase 1/1b
Academic trial Non
Sponsor Lilly
EudraCT Identifier 2019-003581-41
Last update